BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Symdeko (Tezacaftor / ivacaftor) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Symdeko (Tezacaftor / ivacaftor)\, from C
 linicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT03587961-10839@assetmemo.bio
DTSTAMP:20261121T005036Z
DTSTART;VALUE=DATE:20270101
DTEND;VALUE=DATE:20270102
SUMMARY:Symdeko (Tezacaftor / ivacaftor): Phase 1 readout est. (NCT03587961
 )
DESCRIPTION:Symdeko (Tezacaftor / ivacaftor)\, phase 1\, Cystic Fibrosis.\n
 Study: Personalized Theratyping Trial\nEstimated primary completion: 1 Jan
 uary 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout
  date\, and it can move.\nDrug page: https://assetmemo.bio/drug/tezacaftor
 -ivacaftor#upcoming-events\nRegistry record: https://clinicaltrials.gov/st
 udy/NCT03587961
URL:https://assetmemo.bio/drug/tezacaftor-ivacaftor#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
